Dr. Denis Gossen, CSO, Company Co-Founder 

Denis Gossen has over 15 years' experience in the Pharmaceutical and Biotechnology drug development. He received his Ph.D. degree in Applied Biomedical Sciences from Free University of Brussels (ULB, Belgium). He completed a post-doctoral research as a Belgian American Educational Foundation (BAEF) Fellow at Tufts Medical School/New England Medical Center in Boston, MA were his research examined genetic regulatory mechanisms in the ontogeny of gastrointestinal hormones potentially involved in diabetes.

Industry Experience:

Dr. Gossen joined the Development Centre of Eli Lilly (Mont-Saint-Guibert, Belgium) as Clinical Researcher. He held positions of increasing responsibility in the Clinical Pharmacology Department where he served as clinical pharmacologist leading the early clinical development of new molecules.

Denis then joined the therapeutic neurosciences group at UCB (Belgium) as Research Physician and was in charge of the clinical development of new molecules as well as line extensions of existing molecules.

He went back to Eli Lilly and was strongly involved in the identification, development and implementation of biomarkers focusing on proof-of-concept approach with a strong emphasis in pre-clinical/clinical translational approach.

In 2007, Denis has left Lilly and has co-founded Aepodia with Dominique Demolle and former colleagues/peers.